Hilltop National Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
4,897
-137
-3% -$29.5K 0.26% 96
2026
Q1
$1.09M Buy
5,034
+133
+3% +$29.5K 0.26% 97
2025
Q4
$1.12M Sell
4,901
-39
-0.8% -$8.88K 0.27% 98
2025
Q3
$1.14M Sell
4,940
-130
-3% -$26.5K 0.28% 95
2025
Q2
$941K Buy
+5,070
New +$942K 0.25% 100
2024
Q4
$842K Buy
4,736
+108
+2% +$19.9K 0.25% 106
2024
Q3
$914K Sell
4,628
-6
-0.1% -$1.12K 0.28% 94
2024
Q2
$795K Buy
4,634
+109
+2% +$18.1K 0.26% 104
2024
Q1
$824K Buy
+4,525
New +$780K 0.28% 105

Other funds holding ABBV

Hilltop National Bank's ABBV Position: Q2 2026 in Review

Hilltop National Bank reduced its AbbVie (ABBV) stake by 2.7% in Q2 2026, selling an estimated $29.5K and leaving 4,897 shares worth $1.23M. The position accounts for 0.26% of the portfolio, ranked #96.

Hilltop National Bank first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hilltop National Bank held 4,897 shares of AbbVie worth $1.23M as of Q2 2026.
  • Hilltop National Bank sold 137 AbbVie shares in Q2 2026, an estimated $29.5K.
  • AbbVie made up 0.26% of Hilltop National Bank's portfolio in Q2 2026, its #96 holding.
  • Hilltop National Bank first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.